MedDataX Logo

Spanish Registry of Digestive Tumours RETUD

NCT ID: NCT06711211

Last Updated: 2024-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

20000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-23

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this observational study is to assess the current state of digestive tumours in Spain. By doing so, it seeks to enhance the quality of care, optimize the diagnosis and treatment of digestive tumours, and identify opportunities for improvement that can benefit patients.

The study will investigate the epidemiological, biological, and clinical characteristics of digestive tumors diagnosed in patients aged 18 and older across healthcare centres in Spain. It also aims to generate knowledge and scientific evidence for events and situations that may impact on patients with digestive tumours (e.g. COVID-19 coronavirus pandemic).

Furthermore, subject to the patient's consent, biological samples may be collected for use in translational research projects and for the identification of molecular markers that may be useful in healthcare decision-making.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Data will be collected ambispectively, recording those patients who were diagnosed with digestive tumours before the start of the study (from 2017) and also those who are diagnosed after the start of the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Digestive Cancers Bile Duct Cancer Hepatocellular Cancer (HCC) Colorectal Cancer (CRC) Pancreatic Cancer Rectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Biliary Tract Cancer (BTC)

Patients diagnosed with cholangiocarcinoma or gallbladder carcinoma from 01-01-2017.

No interventions assigned to this group

Hepatocellular Carcinoma (HCC)

Patients with hepatocellular carcinoma primary diagnosed from 01-01-2017 and treated with systemic therapy.

No interventions assigned to this group

MSI-High Colorectal Cancer (MSI-H CRC)

Patients with MSI-High colorectal cancer (by PCR or IHQ) and primary pathological diagnosis from 01-01-2017.

No interventions assigned to this group

Pancreatic Cancer

Patients with exocrine pancreatic cancer diagnosed from 01-01-2019.

No interventions assigned to this group

Rectal Cancer

Patients diagnosed with rectal cancer from 01-01-2019.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female patients ≥18 years old diagnosed with oesophageal cancer, gastric cancer, pancreatic cancer, hepatocarcinoma, gallbladder and bile duct cancer, cancer of the small intestine, appendix and gastrointestinal stroma, colorectal cancer, anal canal cancer or digestive hereditary cancer.
* Written informed consent available.

Exclusion Criteria

* Patient for whom, for whatever reason, it is not possible to know or obtain the information necessary to complete the data collection base.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Grupo de Tratamiento de los Tumores Digestivos (TTD)

Madrid, Madrid, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Esther Mahillo, PhD

Role: CONTACT

[email protected]
+34913788275

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TTD-20-01 RETUD RETUD

Identifier Type: -

Identifier Source: org_study_id